SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0000912282-07-000286
Filing Date
2007-03-02
Accepted
2007-03-02 17:00:22
Documents
16
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 oncolytic40f_2006.htm 40-F 61170
2 GRAPHIC ballot.jpg GRAPHIC 751
3 GRAPHIC ballotx.jpg GRAPHIC 762
4 AIF FOR THE YEAR ENDED DECEMBER 31, 2006 ex_1.htm EX-1 411251
5 GRAPHIC img2.gif GRAPHIC 11037
6 GRAPHIC img3.jpg GRAPHIC 4621
7 ex_2.htm EX-2 423806
8 GRAPHIC img1.jpg GRAPHIC 2288
9 MD&A ex_3.htm EX-3 280712
10 SECTION 302 CERTIFICATION - CEO ex_99a.htm EX-99.A 9760
11 SECTION 302 CERTIFICATION - CFO ex_99b.htm EX-99.B 9842
12 SECTION 906 CERTIFICATION - CEO ex_99c.htm EX-99.C 4688
13 SECTION 906 CERTIFICATION - CFO ex_99d.htm EX-99.D 4661
14 CONSENT ex99_e.htm EX-99.E 540
15 GRAPHIC auditorsconsent.jpg GRAPHIC 24290
16 CODE OF ETHICS ex_99f.htm EX-99.F 17876
  Complete submission text file 0000912282-07-000286.txt   1286827
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 40-F | Act: 34 | File No.: 000-31062 | Film No.: 07668553
SIC: 2834 Pharmaceutical Preparations